Pharma Journalist -

InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing agreement aimed at developing a differentiated small-molecule therapy…
Read More...

Illumina has unveiled what it calls the world’s largest genome-wide genetic perturbation dataset, a major initiative designed to accelerate artificial intelligence–driven drug discovery…
Read More...

SciNeuro Pharmaceuticals has entered into a worldwide licensing and collaboration agreement with Novartis Pharma AG to advance a novel antibody program for the treatment of Alzheimer’s…
Read More...

NVIDIA and Eli Lilly and Company have announced the creation of a first-of-its-kind AI co-innovation lab designed to apply artificial intelligence to some of the most persistent…
Read More...

Atara Biotherapeutics has received a setback in its efforts to bring EBVALLO™ (tabelecleucel) to patients with Epstein-Barr virus–positive post-transplant lymphoproliferative disease…
Read More...

AbbVie has announced a voluntary agreement with the Trump administration aimed at expanding access and affordability of medicines for Americans while reinforcing the company’s long-term…
Read More...

AbbVie and RemeGen have entered into an exclusive global licensing agreement aimed at advancing RC148, a novel investigational bispecific antibody targeting both Programmed Cell Death-1…
Read More...

AbbVie and West Pharmaceutical Services have announced a definitive agreement under which AbbVie will acquire a device manufacturing facility and associated intellectual property from…
Read More...

Fortress Biotech, Inc. and its majority-owned subsidiary Cyprium Therapeutics have received a major regulatory milestone with the U.S. Food and Drug Administration’s approval of ZYCUBO®…
Read More...

BD (Becton, Dickinson and Company), a global leader in medical technology, has announced a $110 million investment to expand its production of prefillable syringes in the United States,…
Read More...